IBIO, INC. (IBIO)

Every figure this model derived for IBIO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 560,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-03-31
cash 74,818,000 CashAndCashEquivalentsAtCarryingValue 2026-03-31
current assets 77,251,000 AssetsCurrent 2026-03-31
current liabilities 6,504,000 LiabilitiesCurrent 2026-03-31
equity 77,537,000 StockholdersEquity 2026-03-31
interest expense 143,000 InterestExpenseNonoperating 2026-03-31
ocf -21,605,000 NetCashProvidedByUsedInOperatingActivities 2026-03-31
revenue 300,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-03-31
sbc 1,223,000 ShareBasedCompensation 2026-03-31

The ratios

The figures themselves rather than their scores — what somebody looking up IBIO on one particular measure came for.

RatioValue
current ratio14.43
current ratio reported11.88
deferred revenue growth91.67
dilution pct174.24
interest cover-202.51
revenue growth-20.0
revenue growth per share-70.83
roic-667.96
rule of 40-9673.0
sbc pct revenue407.67

What to be careful about

What this model itself distrusts about IBIO's figures. Written by the derivation as it ran, not added afterwards.